Search results
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 3 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 10 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 4 hours agoThe agency is set to make its decision in April 2025. The news initially sent Novavax stock as high...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 2 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 4 days agoBut in later pandemic days, investors started worrying about Moderna's dependence on its only commercialized product, and that has weighed on the stock...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 6 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...